Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. Reply [0.03%]
关于贝聚妥芬治疗晚期肾细胞癌优于依维莫司的回复
Thomas Powles,Laurence Albiges,Brian Rini
Thomas Powles
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma [0.03%]
替唑利单抗与everolimus（飞尼妥）治疗晚期肾细胞癌的效果比较
Hussam Alkaissi,Karel Pacak,Jared Rosenblum
Hussam Alkaissi
Thomas M Lietman,Ahmed M Arzika,Kieran S O&#x;Brien
Thomas M Lietman
Maple Goh,Aaron S Kesselheim,Kevin Outterson
Maple Goh
Valsan P Verghese,Yogesh Jain,Vasundhara Rangaswamy
Valsan P Verghese
Christian Rosas-Salazar,Leonard B Bacharier,Tina V Hartert
Christian Rosas-Salazar
Patricia Pautier,Jean-Yves Blay,Florence Duffaud
Patricia Pautier
Akhil Santhosh,Annie Baa,Sindhura Chitikela
Akhil Santhosh
A Diagnostic Sequence [0.03%]
诊断序列
Clement Lee,Julie R Barzilay,Emily Ling et al.
Clement Lee et al.
Lorenz C Hofbauer
Lorenz C Hofbauer